18 min listen
In our 200th Episode, IDx Founder Shares Wisdom from Recent Success with the FDA, Venture Investors
In our 200th Episode, IDx Founder Shares Wisdom from Recent Success with the FDA, Venture Investors
ratings:
Length:
27 minutes
Released:
Nov 14, 2018
Format:
Podcast episode
Description
First, thanks to everyone who has helped make the OIS Podcast such a success. We at Healthegy – the producer of the OIS Podcast and events – are grateful for your support. In this week’s episode, we’re visited again by Michael Abramoff, MD, founder and CEO of IDx, the first company to obtain FDA approval for an AI diagnostic tool. In this interview, Dr. Abramoff explains how IDx-DR, an autonomous AI diagnostic for diabetic retinopathy, worked its way through the FDA. He also shares the process he used to raise $33 million from a syndicate of high-powered investors including 8VC, Optum Ventures, Alpha Edison, and Heritage Provider Network. What’s the next step for IDx? Is it an IPO?
Released:
Nov 14, 2018
Format:
Podcast episode
Titles in the series (100)
Ophthalmology Is A “Leading Franchise” At InterWest by OIS Podcast | Ophthalmology's leading Podcast